Literature DB >> 25217329

Improving the outcome of acute cholecystitis: the non-standardized treatment must no longer be employed.

Juan Ignacio González-Muñoz1, María Angoso, José María Sayagués, Ana Belén Sánchez-Casado, Alvaro Hernández, Antonio Velasco, Luís Muñoz-Bellvis.   

Abstract

PURPOSE: Therapeutic recommendations of acute cholecystitis are not consistently implemented, which generates greater patient morbidity and higher health care costs. The aim of this article is to evaluate the burden of acute cholecystitis, to detect potentially modifiable variables, and to propose a therapeutic strategy that will allow us to improve the quality of care.
METHODS: We carried out a retrospective study of patients who were admitted to the hospital from January 2010 to December 2012 using a univariate analysis of parameters including the admitting department, age, treatment administered, and length of stay.
RESULTS: A total of 967 patients were admitted to the hospital with a diagnosis of acute cholecystitis, 692 (72%) to the Surgery Department, 257 (26%) to Internal Medicine-Digestive, and 18 (2%) to other departments. Four hundred ninety-eight (51.5%) were operated on: 107 (21%) on an urgent basis, 111 (22%) at an early stage (<96 h at diagnosis), 152 (30%) at a late stage (>96 h at diagnosis), and 128 (26%) at a delayed date (other admission). Patients who were admitted into the surgery department were five times more likely to be operated on than patients admitted into other departments (p<0.01). Patients operated on at a late stage had a longer length of stay than early stage surgery patients (p<0.05) and than non-operated ones (p<0.05). Patients<74 years old were more frequently operated than older ones (p<0.05).
CONCLUSIONS: The non-standardized treatment of acute cholecystitis causes high clinical and surgical variability, long average stay, more readmissions, and high hospital costs. Therefore, patients with a diagnosis of acute cholecystitis should be admitted to the Surgery Department, thereby increasing the probability of receiving definite treatment.

Entities:  

Mesh:

Year:  2014        PMID: 25217329     DOI: 10.1007/s00423-014-1245-z

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  41 in total

1.  Cost utility of early versus delayed laparoscopic cholecystectomy for acute cholecystitis.

Authors:  Amanda Johner; Adam Raymakers; Sam M Wiseman
Journal:  Surg Endosc       Date:  2012-07-07       Impact factor: 4.584

2.  SAGES guidelines for the clinical application of laparoscopic biliary tract surgery.

Authors:  D Wayne Overby; Keith N Apelgren; William Richardson; Robert Fanelli
Journal:  Surg Endosc       Date:  2010-08-13       Impact factor: 4.584

3.  Acute cholecystitis: early versus delayed cholecystectomy, a multicenter randomized trial (ACDC study, NCT00447304).

Authors:  Carsten N Gutt; Jens Encke; Jörg Köninger; Julian-Camill Harnoss; Kilian Weigand; Karl Kipfmüller; Oliver Schunter; Thorsten Götze; Markus T Golling; Markus Menges; Ernst Klar; Katharina Feilhauer; Wolfram G Zoller; Karsten Ridwelski; Sven Ackmann; Alexandra Baron; Michael R Schön; Helmut K Seitz; Dietmar Daniel; Wolfgang Stremmel; Markus W Büchler
Journal:  Ann Surg       Date:  2013-09       Impact factor: 12.969

4.  A survey of the current surgical treatment of gallstones in Queensland.

Authors:  James Askew
Journal:  ANZ J Surg       Date:  2005-12       Impact factor: 1.872

Review 5.  Early versus delayed laparoscopic cholecystectomy for acute cholecystitis.

Authors:  K S Gurusamy; K Samraj
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

Review 6.  Clinical update: early surgery for acute cholecystitis.

Authors:  Stylianos Germanos; Stavros Gourgiotis; Hemant M Kocher
Journal:  Lancet       Date:  2007-05-26       Impact factor: 79.321

7.  Cost-utility and value-of-information analysis of early versus delayed laparoscopic cholecystectomy for acute cholecystitis.

Authors:  E Wilson; K Gurusamy; C Gluud; B R Davidson
Journal:  Br J Surg       Date:  2010-02       Impact factor: 6.939

8.  TG13 management bundles for acute cholangitis and cholecystitis.

Authors:  Kohji Okamoto; Tadahiro Takada; Steven M Strasberg; Joseph S Solomkin; Henry A Pitt; O James Garden; Markus W Büchler; Masahiro Yoshida; Fumihiko Miura; Yasutoshi Kimura; Ryota Higuchi; Yuichi Yamashita; Toshihiko Mayumi; Harumi Gomi; Shinya Kusachi; Seiki Kiriyama; Masamichi Yokoe; Wan-Yee Lau; Myung-Hwan Kim
Journal:  J Hepatobiliary Pancreat Sci       Date:  2013-01       Impact factor: 7.027

9.  Acute cholecystitis in the diabetic. A case-control study of outcome.

Authors:  M S Hickman; W H Schwesinger; C P Page
Journal:  Arch Surg       Date:  1988-04

10.  Randomised trial of laparoscopic versus open cholecystectomy for acute and gangrenous cholecystitis.

Authors:  T Kiviluoto; J Sirén; P Luukkonen; E Kivilaakso
Journal:  Lancet       Date:  1998-01-31       Impact factor: 79.321

View more
  1 in total

1.  Risk-adjusted treatment selection and outcome of patients with acute cholecystitis.

Authors:  J I González-Muñoz; G Franch-Arcas; M Angoso-Clavijo; M Sánchez-Hernández; A García-Plaza; M Caraballo-Angeli; L Muñoz-Bellvís
Journal:  Langenbecks Arch Surg       Date:  2016-10-04       Impact factor: 3.445

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.